$PRPH News
Last published 10mo ago
- 10mo agoPRPHProPhase Labs Provides Update on Convertible Debt Conversions, Capital Structure, and Underlying Asset ValueGlobeNewswireUNIONDALE, NY, Jan. 05, 2026 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (OTC:PRPH) today provided an update to shareholders regarding recent trading activity, its capital structure, and the Company's underlying asset
- 10mo agoFOLDKBLBPBMPRPHFrom Super Fibers to Super Deals: Science, Scale, and Strategic Capital Shape the Morning TapeGlobeNewswireDENVER, Dec. 19, 2025 (GLOBE NEWSWIRE) -- This morning's market narrative spans futuristic materials, transformational biotech M&A, and creative capital restructuring, underscoring how innovation-driven companies
- 10mo agoPRPHProPhase Labs Signs Non-Binding LOI for Proposed Reverse Merger with Advanced Biological LaboratoriesGlobeNewswireProposed transaction aims to deliver near-term value for ProPhase shareholders, long-term growth for ABL, and create a global, innovation-driven company. Company to hold a virtual conference call today at 10:00 a.m. ET
- 11mo agoPRPHJoin ProPhase Labs' Exclusive Live Investor Webinar and Q&A Session on December 1GlobeNewswireUNIONDALE, NY, Nov. 26, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ:PRPH) is pleased to invite investors to a webinar on December 1, 2025, at 4:15 p.m. ET. The exclusive event, hosted by RedChip Companies,
- 11mo agoPRPHProPhase Labs Reported Results for the Third Quarter Ended September 30, 2025, and Will Hold a Virtual Conference Call Today at 2pm ET.GlobeNewswireProPhase Labs in discussions for strategic initiative to realize significant underlying value in the Company. Voting for Current Proxy Critically Important. Crown Medical Achieves Final Hurdle. Appointed Special Counsel
- 11mo agoPRPHProPhase Labs, Inc. to Present Third Quarter 2025 Financial Results on November 19GlobeNewswireUNIONDALE, NY, Nov. 18, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ:PRPH) (the "Company" or "ProPhase"), a next generation biotech, genomics and consumer products company, announced today that they will be
- 11mo agoPRPHProPhase Labs Urges Shareholders to Vote by November 23 on Proxy ProposalsGlobeNewswireUNIONDALE, NY, Nov. 17, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ:PRPH) reminds shareholders of record as of October 20, 2025, of the Company's upcoming Special Meeting of Stockholders, which will be
- 1y agoPRPHProPhase Labs Announces Publication of BE-Smart Esophageal Cancer Study in the Official Journal of the American College of GastroenterologyGlobeNewswirePeer-Reviewed Study Conducted in Collaboration with Mayo Clinic Demonstrates 100% Sensitivity and Strong Predictive Power for Esophageal Cancer Progression Early Access Programs and Physician Onboarding Initiatives
- 1y agoPRPHProPhase Labs Engages RedChip Companies to Lead Investor Relations EffortsGlobeNewswireUNIONDALE, NY, Oct. 28, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ:PRPH) (the "Company" or "ProPhase"), a next generation biotech, genomics, and consumer products company, today announced that it has engaged
- 1y agoPRPHProPhase Labs to Present at the 2025 ThinkEquity ConferenceGlobeNewswireUNIONDALE, NY, Oct. 24, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ:PRPH) (the "Company" or "ProPhase"), a next generation biotech, genomics, and consumer products company, today announced that it will be
- 1y agoPRPHProPhase Labs Announces Study Validating BE-Smart Esophageal Cancer Test Accepted by Journal of Clinical Gastroenterology and HepatologyGlobeNewswireStudy Acceptance Supports and Provides the Catalyst for Upcoming Commercial Rollout and Revenue-Generating Potential UNIONDALE, NY, Oct. 22, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ:PRPH) ("ProPhase" or the
- 1y agoPRPHPROPHASE LABS, INC. ANNOUNCES COMPLETION OF IMPORTANT NEXT STEP FOR CROWN MEDICAL COLLECTIONS $50 MILLION A/R INITIATIVEGlobeNewswireCOVID-19 TESTING LABORATORY SUBSIDIARIES FILE FOR BANKRUPCTY PROTECTION UNIONDALE, NY, Sept. 23, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ:PRPH) ("ProPhase" or the "Company"), a next generation biotech,
- 1y agoPRPHProPhase Continues its Exploration of a Crypto Treasury StrategyGlobeNewswireUNIONDALE, NY, Sept. 22, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ:PRPH) ("ProPhase" or the "Company"), a next generation biotech, genomics and consumer products company, announced that the Company entered
- 1y agoPRPHProPhase Labs Stockholders Approve All Proposals at September 9, 2025 Special Meeting By More Than 75% In FavorGlobeNewswireProPhase Labs Stockholders Deliver Strong Mandate at Special Meeting UNIONDALE, NY, Sept. 12, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ:PRPH) ("ProPhase" or the "Company"), a next generation biotech,
- 1y agoPRPHProPhase Labs Inc. to Participate in Renmark's Virtual Non-Deal Roadshow Series on Thursday, September 4, 2025GlobeNewswireCompany cancels the Equity Line of Credit (ELOC) UNIONDALE, NY, Sept. 03, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ:PRPH), (the "Company" or "ProPhase"), a next generation biotech, genomics and consumer
- 1y agoPRPHProPhase Labs, Inc. (PRPH) Q2 2025 Earnings Call TranscriptEarnings Call Transcripts
- 1y agoPRPHProPhase Labs Announces Filing of Definitive Proxy Statement and New Date for Special Meeting of ShareholdersGlobeNewswireUNIONDALE, NY, Aug. 19, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ:PRPH) (the "Company" or "ProPhase"), a next generation biotech, genomics and consumer products company, today announced that it filed a
- 1y agoONCYPRPHIOBTOLMA+1Biotech Stocks Rally as Oncology Market Targets $866B by 2034PR NewswireEquity Insider News Commentary – Despite alarming federal budget cuts that stand to potentially harm the national battle against cancer, it appears...
- 1y agoPRPHProPhase Labs Announces Financial Results for the Three and Six Months Ended June 30, 2025GlobeNewswireProPhase Delivers Significant Operational and Financial Improvements, Advances Multiple Non-Dilutive Liquidity Initiatives, and Targets Transformational Growth Catalysts Company granted key U.S. patent on
- 1y agoPRPHProPhase Labs Announces Full USPTO Approval for Issuance of U.S. Patent Protecting Esophageal Adenocarcinoma Risk AssessmentGlobeNewswireU.S. Patent No. 12379378-B2 protects biomarker-driven systems and methods to assess progression risk in Barrett's esophagus and esophageal adenocarcinoma; issuance follows the successful BE-Smart™ test validation
- 1y agoPRPHProPhase Labs Inc. to Present Second Quarter 2025 Financial Results on August 13, 2025GlobeNewswireUNIONDALE, NY, Aug. 11, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ:PRPH), (the "Company" or "ProPhase"), a next generation biotech, genomics and consumer products company, announced today that they will be
- 1y agoPRPHProPhase Labs Announces Special Meeting of Shareholders and Filing of Preliminary Proxy StatementGlobeNewswireProxy Sets Company on a Path to Attract the Optimal Crypto Treasury Strategy Increase in Authorized Shares to 1 Billion Would Position the Company to Attract Industry-Leading Market Participants and High-Value Crypto
- 1y agoPRPHProPhase Labs Announces Closing of $3 Million Senior Secured Convertible Notes FinancingGlobeNewswireFinancing provides bridge to multiple potentially significant liquidity events and crypto strategies UNIONDALE, NY, July 23, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ:PRPH), (the "Company" or
- 1y agoPRPHProPhase Labs Board of Directors Authorizes Management to Explore Strategic Reverse Merger and Approves Crypto Treasury InitiativeGlobeNewswireUNIONDALE, NY, July 21, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ:PRPH), (the "Company" or "ProPhase") a next generation biotech, genomics and consumer products company, today announced that its Board of
- 1y agoPRPHProPhase Labs, Inc. Receives Additional 180 Day Extension from Nasdaq to Regain Compliance with Minimum Bid Price RuleGlobeNewswireUNIONDALE, NY, June 26, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ:PRPH), (the "Company" or "ProPhase") a next generation biotech, genomics and consumer products company, today announced that it has received
- 1y agoONCYGALTPRPHCGON+1Cancer Rates Are Surging in Young Adults -- Here's Where the Smart Money Is GoingPR NewswireUSA News Group News Commentary – According to a recent report in Newsweek, more Americans younger than 50 are getting cancer. In fact, the report...
- 1y agoPRPHProPhase Labs Announces Successful Study Demonstrating Performance of BE-Smart™ Test in Detecting Esophageal CancerGlobeNewswireBE-Smart represents a significant advance in diagnosis and management of Esophageal disease that affects an estimated 60 million people in the United States Study shows >95% success rate, validating BE-Smart for use
- 1y agoPRPHProPhase Labs Announces Formation of Clinical Science Advisory Board to Accelerate Commercialization of BE-SmartTM Esophageal Disease Diagnostic PlatformGlobeNewswireUNIONDALE, NY, June 06, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ:PRPH), (the "Company" or "ProPhase") a next generation biotech, genomics and consumer products company, today announced the formation of its
- 1y agoPRPHProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2025GlobeNewswireHighlights Multiple Significant Potential Liquidity Events Anticipated Within the Next Few Months Completes Significant Reductions in Overhead and Expenses BE-Smart Esophageal Cancer Test Study has been Submitted in
- 1y agoPRPHProPhase Labs Inc. to Present First Quarter 2025 Financial Results on May 20, 2025GlobeNewswireGARDEN CITY, NY, May 13, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ:PRPH), (the "Company" or "ProPhase") a next generation biotech, genomics and consumer products company, announced today that they will be
- 1y agoPRPHProPhase Labs, Inc. Announces Financial Results for the Year Ended December 31, 2024GlobeNewswireCompany to Accelerate BE-Smart Commercialization as a Cash-Pay Diagnostic Significantly reduces overhead, improves margins heading into Q2 2025 Company to hold a conference call Monday, March 31, 2025, at 11:00 AM EST
- 1y agoPRPHProPhase Labs Inc. to Present 2024 Year End Financial Results on March 31, 2025GlobeNewswireGARDEN CITY, NY, March 27, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ:PRPH), (the "Company" or "ProPhase"), a next generation biotech, genomics and consumer products company, today announced that they will be
- 1y agoPRPHProPhase Labs to Present at the Investor Summit Virtual on March 11GlobeNewswireGARDEN CITY, NY, March 07, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ:PRPH) ("ProPhase" or the "Company"), a next-generation biotech, genomics, and consumer products company, today announced that Ted Karkus,
- 1y agoPRPHDiamond Equity Research Releases Update Note on ProPhase Labs Inc. (NASDAQ: PRPH)GlobeNewswireNew York, NY, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading equity research firm with a focus on small capitalization public companies has released an Update Note on ProPhase Labs Inc.
- 1y agoPRPHProPhase Labs Examines Strategic Opportunities to Leverage Its DTC Multi-Media Infrastructure with Telehealth Physician Networks for Prescription DrugsGlobeNewswireCompany Announces Ongoing Strategic Cost Cutting to Focus Resources on new DTC Marketing Initiatives to Drive Growth and Profitability Dispels rumors of an Investment Bank initiating a Capital Raise GARDEN CITY, NY,
- 1y agoPRPHProPhase Labs Announces Excellent Progress with Crown Medical Collections Targeting Over $50 Million in Net Near-Term Cash Recovery from COVID-19 ReceivablesGlobeNewswireCompany Actively Pursuing Strategic Alternatives Including the Potential Sale of Nebula Genomics and DNA Complete to Unlock Immediate Cash GARDEN CITY, NY, Feb. 20, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc.
- 1y agoPRPHProPhase Labs hires Stuart Hollenshead as COO, the former COO and CBO of Barstool SportsGlobeNewswireGARDEN CITY, NY, Feb. 18, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ:PRPH) ("ProPhase" or the "Company"), a next-generation biotech, genomics, and consumer products company, today announced the appointment of
- 1y agoPRPHProPhase Labs Announces Closing of $23.6 Million Sale of Pharmaloz Manufacturing to Houston-Based Private Equity FirmGlobeNewswireTransaction Eliminates More Than $20 Million in Debt, and Other Financial Obligations, Provides $2 million in Cash and Significantly Enhances the Company's Balance Sheet and Liquidity The Company will review with
- 1y agoPRPHProPhase Labs Secures Global Private Equity Backing, Nears Major Lozenge Deal, Adds Seasoned Industry Expert, and Plans Significant Cost-Cutting MeasuresGlobeNewswireThe Company will review on Thursday, December 12th, at 12:00 p.m. EST. GARDEN CITY, NY, Dec. 11, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ:PRPH) ("ProPhase" or the "Company"), a next-generation biotech,
- 1y agoIBOPRPHImpact BioMedical Inc. Issues Shareholder Letter Highlighting Recent Achievements and Strategic VisionGlobeNewswireHOUSTON, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE:IBO), a pioneering biotechnology company dedicated to discovering, developing, and patenting innovative healthcare solutions, today announced that
- 1y agoPRPHDiamond Equity Research Releases Update Note on ProPhase Labs Inc. (NASDAQ: PRPH)GlobeNewswireNew York, NY, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Diamond Equity Research, an equity research firm with a focus on small capitalization public companies has released an Update Note on ProPhase Labs Inc. (NASDAQ:PRPH).
- 1y agoPRPHProPhase Labs, Inc. (PRPH) Q3 2024 Earnings Call TranscriptEarnings Call Transcripts
- 1y agoPRPHProPhase Labs Announces Financial Results for the Three Months Ended September 30, 2024GlobeNewswireHighlights Q4 2024 and Q1 2025 with multiple potential liquidity events, growth in multiple subsidiaries as well as potentially significant reduction in overhead and expenses Company to hold a virtual conference
- 1y agoPRPHProPhase Labs Announces Closing of Public Offering of Common StockGlobeNewswireGARDEN CITY, NY, Nov. 12, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ:PRPH) ("ProPhase" or the "Company"), a next-generation biotech, genomics and diagnostics company, today announced the closing of its
- 2y agoPRPHProPhase Labs Inc. to Present Third Quarter 2024 Financial Results on November 13, 2024GlobeNewswireGARDEN CITY, NY, Nov. 11, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ:PRPH), (the "Company" or "ProPhase"), a next generation biotech, genomics and diagnostics company, today announced that they will be
- 2y agoPRPHProPhase Labs Announces Pricing of Public Offering of Common StockGlobeNewswireGARDEN CITY, NY, Nov. 07, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ:PRPH) ("ProPhase" or the "Company"), a next-generation biotech, genomics and diagnostics company, today announced the pricing of its
- 2y agoPRPHProPhase Labs Announces Proposed Public Offering of Common StockGlobeNewswireGARDEN CITY, NY, Nov. 07, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ:PRPH), a next-generation biotech, genomics and diagnostics company, today announced that it intends to offer to sell shares of its common
- 2y agoPRPHProPhase Labs Launches DNA Complete®: Transforming Direct-to-Consumer Genetic Testing for Health, Wellness, and Enhanced AncestryGlobeNewswireIntroduces DNA Expand Subscription Platform to Enrich Existing DNA Ancestry Data with Comprehensive Health Insights GARDEN CITY, NY, Nov. 04, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ:PRPH) (the "Company"
- 2y agoPRPHProPhase Labs to Present at the 2024 ThinkEquity ConferenceGlobeNewswireGARDEN CITY, NY, Oct. 22, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ:PRPH) (the "Company" or "ProPhase"), a next generation biotech, genomics, and diagnostics company, today announced that it will be
- 2y agoPRPHProPhase Labs Announces Positive Updates on Strategic Initiatives Company Anticipates Multiple Liquidity Events in H1 2025GlobeNewswireProjections for Pharmaloz Manufacturing: Approximately $16-17 Million in Revenue, $6-7 Million in Pre-Tax Earnings for 2025 Strategic Partnership Discussions Begin for BE-Smart Esophageal Cancer Test GARDEN CITY,